Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Deutsches Krebsforschungszentrum
Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts
Deutsches Krebsforschungszentrum Stiftung Des xd6 ffentlichen Rechts
Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts
Deutsches Krebsforschungszentrum Stiftung Des xf6 ffentlichen Rechts
Deutsches Krebsforschungszentrum Stiftung Des xd6 ffentlichen Rechtes
Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechtes
Deutsches Krebsforschungszentrum Stifting Des Offentlichen Rechts
Deutsches Krebsforschungszentrum Stiftung Des Offentlicen Rechts
Deutsches Krebsforschungszentrum Stiftung Des Offentilchen Rechts
Deutsches Krebsforschungszentrum Stiftung Des Oeffentichen Rechts
Deutsches Krebsforschungszentrum Stiftung Des Oeff
Deutsches Krebsforschungszentrum Stiftung Des xd6 ffe
Deutsches Krebsforschungszentrum Stiftung Des xf6 ffentkuchen Rechts
Deutsches Krebsforschungszentrum stiftung Des xd6 ffen
Deutsches Krebsforschungszentrum Stiftung Des xd6 ffetlichen Rechts
Deutsches Krebsforschungszentrum Stiftung Des xd6 ffentlichenrechts
Deutsches Krebsforschungszentrum Stiftung Des xd6 ffentlichen Recht
Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts_20100121
  

Deutsches Krebsforschungszentrum patents

Recent patent applications related to Deutsches Krebsforschungszentrum. Deutsches Krebsforschungszentrum is listed as an Agent/Assignee. Note: Deutsches Krebsforschungszentrum may have other listings under different names/spellings. We're not affiliated with Deutsches Krebsforschungszentrum, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "D" | Deutsches Krebsforschungszentrum-related inventors




Date Deutsches Krebsforschungszentrum patents (updated weekly) - BOOKMARK this page
09/21/17 new patent  Use of parvovirus for eliminating cancer stem cells (cscs)
08/31/1718f-tagged inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
08/31/17Rna viruses expressing il-12 for immunovirotherapy
08/31/17Norovirus antibodies
08/10/17Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essentially consisting of vp3
07/13/17Hcbi, msbi, mssi and cmi sequences as an early marker for the future development of cancer and diseases of the cns and as a target for the treatment and prevention of these diseases
06/15/17Means and methods for diagnosing pancreatic cancer
06/01/17Receptors of rspo2 and rspo3
05/11/17Rna viruses for immunovirotherapy
03/16/17Adenovirus derived helper virus for enhancing recombinant parvovirus production
03/09/17Rearranged tt virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
12/29/16Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (r-spondins) and/or wnt
12/08/16Chromene derivatives and their analogs as wnt pathway antagonists
10/06/16Translation inhibitors in high-dose chemo- and/or high-dose radiotherapy
08/25/16Hcbi sequences as an early marker for the future development of cancer and diseases of the cns and as a target for cancer treatment and prevention
08/18/16Non-ribosomal protein synthesis pigment fusion peptides
08/11/16Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
07/14/16Novel means and methods for treating hbv infection and associated conditions
07/14/16Cytotoxic t cell response modifiers
06/09/16Sensitization of cancer cells to apoptosis induction by flavaglines and 5-hydroxy-flavones
06/09/16Ttv mirna sequences as an early marker for the future development of cancer and as a target for cancer treatment and prevention
03/31/16Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy
03/10/16Contour collimator for radiotherapy
12/31/15Inhibitors of branched-chain-aminotransferase-1 (bcat1) for the treatment of brain tumors
12/17/15Receptors of rspo2 and rspo3
11/05/15Circulating mirnas as early detection marker and prognostic marker
09/03/15Specific tt virus sequences and chimeric tt virus host cell dna molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
08/06/15Multiple orthogonal labelling of oligonucleotides
07/23/15Leaf assembly for a multi-leaf collimator and multi-leaf collimator
06/18/15Leaf module for a multi-leaf collimator and multi-leaf collimator
04/23/15Double-labeled probe for molecular imaging and use thereof
02/19/15B-cell receptor complex binding proteins containing t-cell epitopes
01/29/15Cancer therapy with a parvovirus combined with an hdac inhibitor
01/22/15Means and methods for treating or diagnosing idh1 r132h mutant-positive cancers
01/15/15Biomarker set for identifying a severe form of cancer
01/08/154pi sted fluorescence light microscope with high three-dimensional spatial resolution
12/04/14Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (r-spondins) and/or wnt
11/20/14B7-h6 therapeutically active monoclonal antibody against b7-h6 polypeptide
10/16/14Modified parvovirus useful for gene silencing
10/09/14Means and methods for treating angiogenesis-related diseases
10/02/14Means and methods for treating and/or preventing natural ahr ligand-dependent cancer
09/25/14Therapeutic device for treating a predefined body part of a patient with rays
08/21/14Adeno-parvovirus chimera with enhanced oncolytical potential
08/14/14Gpr177 as target and marker in tumors
08/14/14Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (r-spondins) and/or wnt
07/24/14Oncolytic virotherapy for the therapy of sarcoma
07/10/14Prediction of recurrence for bladder cancer by a protein signature in tissue samples
07/03/14Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (r-spondins) and/or wnt
05/15/14Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (r-spondins) and/or wnt
12/05/13Method for applying a first metal onto a second metal, an isolator or semiconductor substrate, and the respective binding units
11/21/13Inhibitors of branched-chain-aminotransferase-1 (bcat1) for the treatment of brain tumors
11/14/13Chromene derivatives and their analoga as wnt pathway antagonists
11/07/13Chromene derivatives and their analoga as wnt pathway antagonists
10/10/13Means and methods for diagnosing cancer using an antibody which specifically binds to braf v600e
08/29/13Retargeting of rat parvovirus h-1pv to cancer cells through genetic engineering of its capsid
08/15/13Use of parvovirus for eliminating cancer stem cells (cscs)
08/01/13Novel modulators of trail signalling
07/25/13Modified parvovirus having enhanced anti-tumor efficacy
06/13/13High-throughput determining the presence of papillomavirus-neutralizing antibodies in a sample
06/06/13Determination of in vivo dna double-strand break localization and application thereof
05/09/13Probes for genotyping low-risk-hpv
04/11/13Adenovirus derived helper virus for enhancing recombinant parvovirus production
03/28/13Scaffold-based organotypic culture for the long-term cultivation of human epidermal stem cells
03/21/13Methods for the diagnosis and prognosis of a tumor using bcat1 protein
03/07/13Cancer therapy with a parvovirus combined with an hdac inhibitor
Patent Packs
02/21/13Means and methods for diagnosing pancreatic cancer
01/31/13Means and methods for predicting the risk of mortality of patients with hpv positive oropharyngeal squamous cell cancer
11/22/12Compounds inhibiting cd95 signaling for the treatment of pancreatic cancer
10/18/12Receptors of rspo2 and rspo3
08/23/12Three-dimensionally localizing light emitting molecules of unknown orientation and unknown z-position
08/09/12Modified aav capsid polypeptides
06/21/12Tricyclic pyrimidine derivatives as wnt antagonists
05/31/12Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essentially consisting of vp3
05/10/12Enhanced production of papillomavirus-like particles with a modified baculovirus expression system
05/03/12Fluorescence light scanning microscope having a birefringent chromatic beam shaping device
02/16/12Rspondin-3 inhibition in bone disorders
02/16/12Diagnostic transcript and splice patterns of hpv16 in different cervical lesions
12/29/11Specific tt virus sequences and chimeric tt virus host cell dna molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
12/08/11Death receptor cd95 controls neurogenesis of adult neural stem cells in vivo and in vitro
11/10/11Diagnostic transcript and splice patterns of hr-hpv in different cervical lesions
Patent Packs
10/13/11Method and device for dynamically shifting a light beam with regard to an optic focussing the light beam
06/16/11Measles virus for the elimination of unwanted cell populations
05/26/11Hmgb1 for cancer treatment
02/10/11Parvovirus having a cpg-enriched genome useful for cancer therapy
12/23/10Animal model based on targeted apoptosis for the study of genetic diseases such as parkinson's disease
11/04/10Method for determining the concentration of a molecule
09/16/10Method, computer program and workstation for removing undesirable objects from a digital medical image
07/30/09Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or wnt
03/19/09Collimator for defining a beam of high-energy rays
09/07/17Method for the detection of antigen presentation
05/03/12System and computer assisted surgery
02/05/09Optical imaging detector
10/14/10Gene expression signature for the prognosis, diagnosis, and therapy of prostate cancer and uses thereof
05/11/17Methods for the prediction of a personalized esa-dose in the treatment of anemia
02/09/17Pancreatic cancer therapy and diagnosis
06/15/17Mammalian dickkopf 3 (dkk3) as urinary marker for chronic kidney diseases
02/02/17S100p and hyaluronic acid as biomarkers for metastatic breast cancer
10/27/16Novel promiscuous hpv16-derived t helper epitopes for immunotherapy
04/28/16Treatment of insulin resistance through inhibitors of transcription factor tsc22d4
01/14/16Rspondins as modulators of angiogenesis and vasculogenesis
11/24/11Compositions for diagnosis and therapy of diseases associated with aberrant expression of kremen and/or wnt
11/12/09Cell culture of keratinocytes under non-differentiating conditions
01/05/17Inhibitors of thioredoxin-interacting protein (txnip) for therapy
06/04/15Inhibitors of thioredoxin-interacting protein (txnip) for therapy
06/19/14Modulators of adp-dependent glucokinase (adpgk) and glycerol-3-phosphate dehydrogenase (gpd2) for therapy
04/28/16Modulators of adp-dependent glucokinase (adpgk) and glycerol-3-phosphate dehydrogenase (gpd2) for therapy
08/13/09Diagnosis and therapy of cell proliferative disorders characterized by resistance to trail induced apoptosis
09/01/16Micrornas modulating the effect of glucocorticoid signaling
09/19/13Visualization of anatomical data by augmented reality
10/11/12Treatment of tumors using specific anti-l1 antibody
Social Network Patent Pack
08/23/12Method for cancer therapy based on a co-administration of a parvovirus and a cytokine
02/09/12Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
08/04/11Use of cd95 inhibitors for the treatment of inflammatory disorders
07/14/11Inhibition of angiogenesis and tumor metastasis
05/19/11Inhibitor protein of the wnt signal pathway
12/02/10Methods and compounds for treating diseases caused by reactive oxygen species
06/10/10Fusion polypeptide suitable as a cytotoxin
03/25/10Method, system and computer program product for targeting of a target with an elongate instrument
02/04/10Compositions comprising a parvovirus vp1-variant and a parvovirus ns1 protein for induction of cytolysis
01/21/10Process for the covalent coupling of two molecules by means of a diels-alder reaction with inverse electron requirement
Patent Packs
09/03/09Antibodies active against a fusion polypeptide comprising a histidine portion
06/25/09Treatment of tumors using specific anti-l1 antibody
05/28/09Riproximin, a novel type ii ribosome-inactivating protein and uses thereof
03/05/09Inverse treatment planning method
01/21/10Process for the covalent coupling of two molecules by means of a diels-alder reaction with inverse electron requirement
03/09/17Rearranged tt virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
10/03/13Rearranged tt virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
02/27/14Rspondins as modulators of angiogenesis and vasculogenesis
09/10/09Method to inhibit the propagation of an undesired cell population
12/22/16Method for cancer therapy based on co-administration of a parvovirus and a cytokine
04/28/16Neutralization of cd95 activity blocks invasion of glioblastoma cells in vivo
08/21/14Parvovirus cancer therapy and combination with chemotherapy
05/01/14Treatment of tumors using specific anti-l1 antibody
10/28/10Method and device for defining a beam of high-energy rays
01/09/14Position sensoring a multi-leaf collimator
12/26/13Parovirus having a cpg-enriched genome useful for cancer therapy
06/25/09Method of selecting a desired protein from a library







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Deutsches Krebsforschungszentrum in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Deutsches Krebsforschungszentrum with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';